These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7051508)

  • 1. Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma.
    Sadoughi N; Mlsna J; Guinan P; Rubenstone A
    Urology; 1982 Aug; 20(2):143-6. PubMed ID: 7051508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method.
    Coon JS; Weinstein RS
    Am J Clin Pathol; 1981 Aug; 76(2):163-71. PubMed ID: 7023226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of specific red-cell adherence and immunoperoxidase staining techniques for ABO(H) blood-group cell-surface antigens on superficial transitional cell carcinoma of the bladder.
    Boileau MA; Cowles RS; Schmidt KL; Schmidt WA
    J Surg Oncol; 1985 Oct; 30(2):72-9. PubMed ID: 3908825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
    Richie JP; Blute RD; Waisman J
    J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 9. The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder.
    Young AK; Hammond E; Middleton AW
    J Urol; 1979 Oct; 122(4):462-4. PubMed ID: 480485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified immunoperoxidase method for the detection of ABH tissue isoantigens in patients with bladder carcinoma.
    Stul MS; Logghe GN; Bergmans GB; Vanvuchelen JK
    Exp Pathol; 1985; 27(2):119-22. PubMed ID: 3888650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface A, B, or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma.
    Newman AJ; Carlton CE; Johnson S
    J Urol; 1980 Jul; 124(1):27-9. PubMed ID: 7411715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoperoxidase versus specific red cell adherence in detection of ABO(H) antigens on normal urothelium. Double-blind study.
    McAlpine RG; Javadpour N; Vafier JA; Worsham GF; O'Connell KJ
    Urology; 1984 Aug; 24(2):153-6. PubMed ID: 6380084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface antigen in bilharzial bladder tumours.
    Halim A; Javadpour N; Kasraeian A; Young JD
    Br J Urol; 1986 Oct; 58(5):523-5. PubMed ID: 3096417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered reactivity for A, B, H antigens in transitional cell carcinomas of the urinary bladder. A study of the mechanisms involved.
    Limas C; Lange P
    Cancer; 1980 Sep; 46(6):1366-73. PubMed ID: 7417937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue blood-group antigens and prognosis in low stage transitional cell carcinoma of the bladder.
    Lange PH; Limas C; Fraley EE
    J Urol; 1978 Jan; 119(1):52-5. PubMed ID: 621815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.
    Zorzos J; Zizi A; Bakiras A; Pectasidis D; Skarlos DV; Zorzos H; Elemenoglou J; Likourinas M
    Eur Urol; 1995; 28(3):251-4. PubMed ID: 8536781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of A, B and H(O) antigens in normal and neoplastic epithelium of the urinary bladder by the specific red cell adherence test (SRCA).
    Kato T
    Tohoku J Exp Med; 1977 Mar; 121(3):239-46. PubMed ID: 857340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherence.
    Flanigan RC; King CT; Clark TD; Cash JB; Greenfield BJ; Sniecinski IJ; Primus FJ
    J Urol; 1983 Sep; 130(3):499-503. PubMed ID: 6350617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.